Patent · US Active

Use of aromatase inhibitors for treatment of ectopic pregnancy

US8685950B2 · kind B2 · utility

0Cited by

2References

16Claims

0Family size

Assignee

Wayne State University · US

Inventors

Mohamed F. M. Mitwally · North York, CA
Michael Diamond · Grosse Pointe Park, US
Robert Casper · Toronto, CA

Key dates

Filing date	Oct 4, 2005
Grant date	Apr 1, 2014
Priority date	—
Expiry date	May 13, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Following a diagnosis of ectopic pregnancy, at least one aromatase inhibitor, is administered to a patient, either alone or in combination with other aromatase inhibitors or therapeutic agents or as an adjuvant to conservative surgical treatment, such as laparoscopy, to prevent the establishment and/or continuation of the ectopic pregnancy. In certain preferred embodiments, the aromatase inhibitor is administered in conjunction with methotrexate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.